Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

Evaluation of the gradient concentration strip method for antifungal susceptibility testing of isavuconazole and comparators for Mucorales species.

Vidal P, Schwarz P, Dannaoui E.

Antimicrob Agents Chemother. 2019 Jul 29. pii: AAC.00838-19. doi: 10.1128/AAC.00838-19. [Epub ahead of print]

PMID:
31358578
2.

Identification of Mucorales by Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry.

Schwarz P, Guedouar H, Laouiti F, Grenouillet F, Dannaoui E.

J Fungi (Basel). 2019 Jul 2;5(3). pii: E56. doi: 10.3390/jof5030056.

3.

Multicentre study to determine the Etest epidemiological cut-off values of antifungal drugs in Candida spp. and Aspergillus fumigatus species complex.

Salsé M, Gangneux JP, Cassaing S, Delhaes L, Fekkar A, Dupont D, Botterel F, Costa D, Bourgeois N, Bouteille B, Houzé S, Dannaoui E, Guegan H, Charpentier E, Persat F, Favennec L, Lachaud L, Sasso M.

Clin Microbiol Infect. 2019 May 11. pii: S1198-743X(19)30205-8. doi: 10.1016/j.cmi.2019.04.027. [Epub ahead of print]

PMID:
31082487
4.

In vitro interactions between isavuconazole and tacrolimus, cyclosporin A or sirolimus against Mucorales.

Schwarz P, Schwarz PV, Felske-Zech H, Dannaoui E.

J Antimicrob Chemother. 2019 Jul 1;74(7):1921-1927. doi: 10.1093/jac/dkz102.

PMID:
30934052
5.

Antifungal combinations in Mucorales: A microbiological perspective.

Schwarz P, Cornely OA, Dannaoui E.

Mycoses. 2019 Sep;62(9):746-760. doi: 10.1111/myc.12909. Epub 2019 Jul 19. Review.

PMID:
30830980
6.

Interactions of Aspergillus fumigatus and Stenotrophomonas maltophilia in an in vitro Mixed Biofilm Model: Does the Strain Matter?

Melloul E, Roisin L, Durieux MF, Woerther PL, Jenot D, Risco V, Guillot J, Dannaoui E, Decousser JW, Botterel F.

Front Microbiol. 2018 Nov 27;9:2850. doi: 10.3389/fmicb.2018.02850. eCollection 2018.

7.

Aspergillus pseudodeflectus: a new human pathogen in liver transplant patients.

Aït-Ammar N, Levesque E, Murat JB, Imbert S, Foulet F, Dannaoui E, Botterel F.

BMC Infect Dis. 2018 Dec 12;18(1):648. doi: 10.1186/s12879-018-3527-5.

8.

Occurrence and species diversity of human-pathogenic Mucorales in commercial food-stuffs purchased in Paris area.

Mousavi B, Botterel F, Costa JM, Arné P, Guillot J, Dannaoui E.

Med Mycol. 2018 Nov 14. doi: 10.1093/mmy/myy121. [Epub ahead of print]

PMID:
30428080
9.

Prevalence, geographic risk factor, and development of a standardized protocol for fungal isolation in cystic fibrosis: Results from the international prospective study "MFIP".

Delhaes L, Touati K, Faure-Cognet O, Cornet M, Botterel F, Dannaoui E, Morio F, Le Pape P, Grenouillet F, Favennec L, Le Gal S, Nevez G, Duhamel A, Borman A, Saegeman V, Lagrou K, Gomez E, Carro ML, Canton R, Campana S, Buzina W, Chen S, Meyer W, Roilides E, Simitsopoulou M, Manso E, Cariani L, Biffi A, Fiscarelli E, Ricciotti G, Pihet M, Bouchara JP.

J Cyst Fibros. 2019 Mar;18(2):212-220. doi: 10.1016/j.jcf.2018.10.001. Epub 2018 Oct 20. No abstract available.

PMID:
30348610
10.

Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in Candida and Aspergillus Species for the Sensititre YeastOne Colorimetric Broth and Etest Agar Diffusion Methods.

Espinel-Ingroff A, Turnidge J, Alastruey-Izquierdo A, Botterel F, Canton E, Castro C, Chen YC, Chen Y, Chryssanthou E, Dannaoui E, Garcia-Effron G, Gonzalez GM, Govender NP, Guinea J, Kidd S, Lackner M, Lass-Flörl C, Linares-Sicilia MJ, López-Soria L, Magobo R, Pelaez T, Quindós G, Rodriguez-Iglesia MA, Ruiz MA, Sánchez-Reus F, Sanguinetti M, Shields R, Szweda P, Tortorano A, Wengenack NL, Bramati S, Cavanna C, DeLuca C, Gelmi M, Grancini A, Lombardi G, Meletiadis J, Negri CE, Passera M, Peman J, Prigitano A, Sala E, Tejada M.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01651-18. doi: 10.1128/AAC.01651-18. Print 2019 Jan.

11.

Candida auris: An emerging drug resistant yeast - A mini-review.

Bidaud AL, Chowdhary A, Dannaoui E.

J Mycol Med. 2018 Sep;28(3):568-573. doi: 10.1016/j.mycmed.2018.06.007. Epub 2018 Jul 17. Review.

PMID:
30030072
12.

In vitro combination of voriconazole with micafungin against azole-resistant clinical isolates of Aspergillus fumigatus from different geographical regions.

Fakhim H, Vaezi A, Dannaoui E, Sharma C, Mousavi B, Chowdhary A, Meis JF, Badali H.

Diagn Microbiol Infect Dis. 2018 Jul;91(3):266-268. doi: 10.1016/j.diagmicrobio.2018.03.003. Epub 2018 Mar 8.

PMID:
29622284
13.

Comparative virulence of Candida auris with Candida haemulonii, Candida glabrata and Candida albicans in a murine model.

Fakhim H, Vaezi A, Dannaoui E, Chowdhary A, Nasiry D, Faeli L, Meis JF, Badali H.

Mycoses. 2018 Jun;61(6):377-382. doi: 10.1111/myc.12754. Epub 2018 Mar 14.

PMID:
29460345
14.

Species Identification and In Vitro Antifungal Susceptibility of Aspergillus terreus Species Complex Clinical Isolates from a French Multicenter Study.

Imbert S, Normand AC, Ranque S, Costa JM, Guitard J, Accoceberry I, Bonnal C, Fekkar A, Bourgeois N, Houzé S, Hennequin C, Piarroux R, Dannaoui E, Botterel F.

Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e02315-17. doi: 10.1128/AAC.02315-17. Print 2018 May.

15.

Posaconazole MIC Distributions for Aspergillus fumigatus Species Complex by Four Methods: Impact of cyp51A Mutations on Estimation of Epidemiological Cutoff Values.

Espinel-Ingroff A, Turnidge J, Alastruey-Izquierdo A, Dannaoui E, Garcia-Effron G, Guinea J, Kidd S, Pelaez T, Sanguinetti M, Meletiadis J, Botterel F, Bustamante B, Chen YC, Chakrabarti A, Chowdhary A, Chryssanthou E, Córdoba S, Gonzalez GM, Guarro J, Johnson EM, Kus JV, Lass-Flörl C, Linares-Sicilia MJ, Martín-Mazuelos E, Negri CE, Pfaller MA, Tortorano AM.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e01916-17. doi: 10.1128/AAC.01916-17. Print 2018 Apr.

16.

In vitro antifungal activity of amphotericin B and 11 comparators against Aspergillus terreus species complex.

Vaezi A, Fakhim H, Arastehfar A, Shokohi T, Hedayati MT, Khodavaisy S, Rezaei-Matehkolaei A, Badiee P, Hagen F, Lass-Flörl C, Dannaoui E, Meis JF, Badali H.

Mycoses. 2018 Feb;61(2):134-142. doi: 10.1111/myc.12716. Epub 2017 Nov 22.

PMID:
29064123
17.

In Vitro Combination of Isavuconazole with Echinocandins against Azole-Susceptible and -Resistant Aspergillus spp.

Raffetin A, Courbin V, Jullien V, Dannaoui E.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e01382-17. doi: 10.1128/AAC.01382-17. Print 2018 Jan.

18.

Occurrence and species distribution of pathogenic Mucorales in unselected soil samples from France.

Mousavi B, Costa JM, Arné P, Guillot J, Chermette R, Botterel F, Dannaoui E.

Med Mycol. 2018 Apr 1;56(3):315-321. doi: 10.1093/mmy/myx051.

PMID:
28992337
19.

PCR-based detection of Aspergillus fumigatus and absence of azole resistance due to TR34 /L98H in a french multicenter cohort of 137 patients with fungal rhinosinusitis.

Morio F, Dannaoui E, Chouaki T, Cateau E, Malard O, Bonfils P, Page C, Dufour X, Cottrel C, Erwan T, Lavergne RA, Le Pape P.

Mycoses. 2018 Jan;61(1):30-34. doi: 10.1111/myc.12702. Epub 2017 Sep 26.

PMID:
28922487
20.

In Vitro Interactions of Echinocandins with Triazoles against Multidrug-Resistant Candida auris.

Fakhim H, Chowdhary A, Prakash A, Vaezi A, Dannaoui E, Meis JF, Badali H.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e01056-17. doi: 10.1128/AAC.01056-17. Print 2017 Nov.

21.

Molecular Diagnosis of Invasive Aspergillosis and Detection of Azole Resistance by a Newly Commercialized PCR Kit.

Dannaoui E, Gabriel F, Gaboyard M, Lagardere G, Audebert L, Quesne G, Godichaud S, Verweij PE, Accoceberry I, Bougnoux ME.

J Clin Microbiol. 2017 Nov;55(11):3210-3218. doi: 10.1128/JCM.01032-17. Epub 2017 Aug 16.

22.

Antifungal resistance in mucorales.

Dannaoui E.

Int J Antimicrob Agents. 2017 Nov;50(5):617-621. doi: 10.1016/j.ijantimicag.2017.08.010. Epub 2017 Aug 9. Review.

PMID:
28802855
23.

Azole Resistance in Aspergillus fumigatus in Patients with Cystic Fibrosis: A Matter of Concern?

Hamprecht A, Morio F, Bader O, Le Pape P, Steinmann J, Dannaoui E.

Mycopathologia. 2018 Feb;183(1):151-160. doi: 10.1007/s11046-017-0162-4. Epub 2017 Jun 26. Review.

PMID:
28653258
24.

Clinical outcome of cystic fibrosis patients colonized by Scedosporium species following lung transplantation: A single-center 15-year experience.

Parize P, Boussaud V, Poinsignon V, Sitterlé E, Botterel F, Lefeuvre S, Guillemain R, Dannaoui E, Billaud EM.

Transpl Infect Dis. 2017 Oct;19(5). doi: 10.1111/tid.12738. Epub 2017 Aug 1.

PMID:
28618155
25.

Fatal Pulmonary Mucormycosis due to Rhizopus homothallicus.

Compain F, Aït-Ammar N, Botterel F, Gibault L, Le Pimpec Barthes F, Dannaoui E.

Mycopathologia. 2017 Oct;182(9-10):907-913. doi: 10.1007/s11046-017-0151-7. Epub 2017 Jun 3.

PMID:
28580534
26.

An ultra performance liquid chromatography-tandem mass spectrometry method for the therapeutic drug monitoring of isavuconazole and seven other antifungal compounds in plasma samples.

Toussaint B, Lanternier F, Woloch C, Fournier D, Launay M, Billaud E, Dannaoui E, Lortholary O, Jullien V.

J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Mar 1;1046:26-33. doi: 10.1016/j.jchromb.2017.01.036. Epub 2017 Jan 23.

PMID:
28131025
27.

Characteristics of Aspergillus fumigatus in Association with Stenotrophomonas maltophilia in an In Vitro Model of Mixed Biofilm.

Melloul E, Luiggi S, Anaïs L, Arné P, Costa JM, Fihman V, Briard B, Dannaoui E, Guillot J, Decousser JW, Beauvais A, Botterel F.

PLoS One. 2016 Nov 21;11(11):e0166325. doi: 10.1371/journal.pone.0166325. eCollection 2016.

28.

Echinocandin Resistance in Candida Species Isolates from Liver Transplant Recipients.

Prigent G, Aït-Ammar N, Levesque E, Fekkar A, Costa JM, El Anbassi S, Foulet F, Duvoux C, Merle JC, Dannaoui E, Botterel F.

Antimicrob Agents Chemother. 2017 Jan 24;61(2). pii: e01229-16. doi: 10.1128/AAC.01229-16. Print 2017 Feb.

29.

Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method.

Espinel-Ingroff A, Arendrup M, Cantón E, Cordoba S, Dannaoui E, García-Rodríguez J, Gonzalez GM, Govender NP, Martin-Mazuelos E, Lackner M, Lass-Flörl C, Linares Sicilia MJ, Rodriguez-Iglesias MA, Pelaez T, Shields RK, Garcia-Effron G, Guinea J, Sanguinetti M, Turnidge J.

Antimicrob Agents Chemother. 2016 Dec 27;61(1). pii: e01792-16. doi: 10.1128/AAC.01792-16. Print 2017 Jan.

30.

In Vitro Activities of Novel Azole Compounds ATTAF-1 and ATTAF-2 against Fluconazole-Susceptible and -Resistant Isolates of Candida Species.

Fakhim H, Emami S, Vaezi A, Hashemi SM, Faeli L, Diba K, Dannaoui E, Badali H.

Antimicrob Agents Chemother. 2016 Dec 27;61(1). pii: e01106-16. doi: 10.1128/AAC.01106-16. Print 2017 Jan.

31.

Multicenter Comparison of the Etest and EUCAST Methods for Antifungal Susceptibility Testing of Candida Isolates to Micafungin.

Bougnoux ME, Dannaoui E, Accoceberry I, Angoulvant A, Bailly E, Botterel F, Chevrier S, Chouaki T, Cornet M, Dalle F, Datry A, Dupuis A, Fekkar A, Gangneux JP, Guitard J, Hennequin C, Le Govic Y, Le Pape P, Maubon D, Ranque S, Sautour M, Sendid B, Chandenier J.

Antimicrob Agents Chemother. 2016 Jul 22;60(8):5088-91. doi: 10.1128/AAC.00630-16. Print 2016 Aug.

32.

Reducing hypoxia and inflammation during invasive pulmonary aspergillosis by targeting the Interleukin-1 receptor.

Gresnigt MS, Rekiki A, Rasid O, Savers A, Jouvion G, Dannaoui E, Parlato M, Fitting C, Brock M, Cavaillon JM, van de Veerdonk FL, Ibrahim-Granet O.

Sci Rep. 2016 May 24;6:26490. doi: 10.1038/srep26490.

33.

Novel Taxa Associated with Human Fungal Black-Grain Mycetomas: Emarellia grisea gen. nov., sp. nov., and Emarellia paragrisea sp. nov.

Borman AM, Desnos-Ollivier M, Campbell CK, Bridge PD, Dannaoui E, Johnson EM.

J Clin Microbiol. 2016 Jul;54(7):1738-1745. doi: 10.1128/JCM.00477-16. Epub 2016 Apr 13.

34.

Prospective evaluation of azole resistance in Aspergillus fumigatus clinical isolates in France.

Choukri F, Botterel F, Sitterlé E, Bassinet L, Foulet F, Guillot J, Costa JM, Fauchet N, Dannaoui E.

Med Mycol. 2015 Aug;53(6):593-6. doi: 10.1093/mmy/myv029. Epub 2015 May 30.

PMID:
26026171
35.

Next-generation sequencing offers new insights into the resistance of Candida spp. to echinocandins and azoles.

Garnaud C, Botterel F, Sertour N, Bougnoux ME, Dannaoui E, Larrat S, Hennequin C, Guinea J, Cornet M, Maubon D.

J Antimicrob Chemother. 2015 Sep;70(9):2556-65. doi: 10.1093/jac/dkv139. Epub 2015 May 27.

PMID:
26017039
36.

Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus.

van der Linden JW, Arendrup MC, Warris A, Lagrou K, Pelloux H, Hauser PM, Chryssanthou E, Mellado E, Kidd SE, Tortorano AM, Dannaoui E, Gaustad P, Baddley JW, Uekötter A, Lass-Flörl C, Klimko N, Moore CB, Denning DW, Pasqualotto AC, Kibbler C, Arikan-Akdagli S, Andes D, Meletiadis J, Naumiuk L, Nucci M, Melchers WJ, Verweij PE.

Emerg Infect Dis. 2015 Jun;21(6):1041-4. doi: 10.3201/eid2106.140717.

37.

In vitro activity of miltefosine in combination with voriconazole or amphotericin B against clinical isolates of Scedosporium spp.

Compain F, Botterel F, Sitterlé E, Paugam A, Bougnoux ME, Dannaoui E.

J Med Microbiol. 2015 Mar;64(Pt 3):309-11. doi: 10.1099/jmm.0.000019. Epub 2015 Jan 16. No abstract available.

PMID:
25596124
38.

Multicenter evaluation of MIC distributions for epidemiologic cutoff value definition to detect amphotericin B, posaconazole, and itraconazole resistance among the most clinically relevant species of Mucorales.

Espinel-Ingroff A, Chakrabarti A, Chowdhary A, Cordoba S, Dannaoui E, Dufresne P, Fothergill A, Ghannoum M, Gonzalez GM, Guarro J, Kidd S, Lass-Flörl C, Meis JF, Pelaez T, Tortorano AM, Turnidge J.

Antimicrob Agents Chemother. 2015 Mar;59(3):1745-50. doi: 10.1128/AAC.04435-14. Epub 2015 Jan 12.

39.

Molecular identification of fungi found on decomposed human bodies in forensic autopsy cases.

Schwarz P, Dannaoui E, Gehl A, Felske-Zech H, Birngruber CG, Dettmeyer RB, Verhoff MA.

Int J Legal Med. 2015 Jul;129(4):785-91. doi: 10.1007/s00414-014-1118-6. Epub 2014 Nov 15.

PMID:
25398636
40.

In vitro combination of voriconazole and miltefosine against clinically relevant molds.

Imbert S, Palous M, Meyer I, Dannaoui E, Mazier D, Datry A, Fekkar A.

Antimicrob Agents Chemother. 2014 Nov;58(11):6996-8. doi: 10.1128/AAC.03212-14. Epub 2014 Sep 8.

41.

Emergence of echinocandin-resistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy?

Fekkar A, Dannaoui E, Meyer I, Imbert S, Brossas JY, Uzunov M, Mellon G, Nguyen S, Guiller E, Caumes E, Leblond V, Mazier D, Fievet MH, Datry A.

Eur J Clin Microbiol Infect Dis. 2014 Sep;33(9):1489-96. doi: 10.1007/s10096-014-2096-9. Epub 2014 Apr 9.

PMID:
24715154
42.

Mutations in the Cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus isolated from avian farms in France and China.

Wang DY, Gricourt M, Arné P, Thierry S, Seguin D, Chermette R, Huang WY, Dannaoui E, Botterel F, Guillot J.

Poult Sci. 2014 Jan;93(1):12-5. doi: 10.3382/ps.2013-03541.

PMID:
24570417
43.

ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others.

Tortorano AM, Richardson M, Roilides E, van Diepeningen A, Caira M, Munoz P, Johnson E, Meletiadis J, Pana ZD, Lackner M, Verweij P, Freiberger T, Cornely OA, Arikan-Akdagli S, Dannaoui E, Groll AH, Lagrou K, Chakrabarti A, Lanternier F, Pagano L, Skiada A, Akova M, Arendrup MC, Boekhout T, Chowdhary A, Cuenca-Estrella M, Guinea J, Guarro J, de Hoog S, Hope W, Kathuria S, Lortholary O, Meis JF, Ullmann AJ, Petrikkos G, Lass-Flörl C; European Society of Clinical Microbiology and Infectious Diseases Fungal Infection Study Group; European Confederation of Medical Mycology.

Clin Microbiol Infect. 2014 Apr;20 Suppl 3:27-46. doi: 10.1111/1469-0691.12465.

44.

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi.

Chowdhary A, Meis JF, Guarro J, de Hoog GS, Kathuria S, Arendrup MC, Arikan-Akdagli S, Akova M, Boekhout T, Caira M, Guinea J, Chakrabarti A, Dannaoui E, van Diepeningen A, Freiberger T, Groll AH, Hope WW, Johnson E, Lackner M, Lagrou K, Lanternier F, Lass-Flörl C, Lortholary O, Meletiadis J, Muñoz P, Pagano L, Petrikkos G, Richardson MD, Roilides E, Skiada A, Tortorano AM, Ullmann AJ, Verweij PE, Cornely OA, Cuenca-Estrella M; European Society of Clinical Microbiology and Infectious Diseases Fungal Infection Study Group; European Confederation of Medical Mycology.

Clin Microbiol Infect. 2014 Apr;20 Suppl 3:47-75. doi: 10.1111/1469-0691.12515.

45.

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013.

Cornely OA, Arikan-Akdagli S, Dannaoui E, Groll AH, Lagrou K, Chakrabarti A, Lanternier F, Pagano L, Skiada A, Akova M, Arendrup MC, Boekhout T, Chowdhary A, Cuenca-Estrella M, Freiberger T, Guinea J, Guarro J, de Hoog S, Hope W, Johnson E, Kathuria S, Lackner M, Lass-Flörl C, Lortholary O, Meis JF, Meletiadis J, Muñoz P, Richardson M, Roilides E, Tortorano AM, Ullmann AJ, van Diepeningen A, Verweij P, Petrikkos G; European Society of Clinical Microbiology and Infectious Diseases Fungal Infection Study Group; European Confederation of Medical Mycology.

Clin Microbiol Infect. 2014 Apr;20 Suppl 3:5-26. doi: 10.1111/1469-0691.12371.

46.

Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?

Espinel-Ingroff A, Arendrup MC, Pfaller MA, Bonfietti LX, Bustamante B, Canton E, Chryssanthou E, Cuenca-Estrella M, Dannaoui E, Fothergill A, Fuller J, Gaustad P, Gonzalez GM, Guarro J, Lass-Flörl C, Lockhart SR, Meis JF, Moore CB, Ostrosky-Zeichner L, Pelaez T, Pukinskas SR, St-Germain G, Szeszs MW, Turnidge J.

Antimicrob Agents Chemother. 2013 Dec;57(12):5836-42. doi: 10.1128/AAC.01519-13. Epub 2013 Sep 9.

47.

Acremonium sclerotigenum-Acremonium egyptiacum: a multi-resistant fungal pathogen complicating the course of aplastic anaemia.

Guitard J, Degulys A, Buot G, Aline-Fardin A, Dannaoui E, Rio B, Marie JP, Lapusan S, Hennequin C.

Clin Microbiol Infect. 2014 Jan;20(1):O30-2. doi: 10.1111/1469-0691.12319. Epub 2013 Aug 30.

48.

Rapid emergence of echinocandin resistance during Candida kefyr fungemia treatment with caspofungin.

Fekkar A, Meyer I, Brossas JY, Dannaoui E, Palous M, Uzunov M, Nguyen S, Leblond V, Mazier D, Datry A.

Antimicrob Agents Chemother. 2013 May;57(5):2380-2. doi: 10.1128/AAC.02037-12. Epub 2013 Feb 25.

49.

Estimating the burden of mucormycosis infections in France (2005-2007) through a capture-recapture method on laboratory and administrative data.

Bitar D, Morizot G, Van Cauteren D, Dannaoui E, Lanternier F, Lortholary O, Dromer F.

Rev Epidemiol Sante Publique. 2012 Oct;60(5):383-7. doi: 10.1016/j.respe.2012.03.007. Epub 2012 Sep 26.

PMID:
23020929
50.

Mucormycosis after allogeneic haematopoietic stem cell transplantation: a French Multicentre Cohort Study (2003-2008).

Xhaard A, Lanternier F, Porcher R, Dannaoui E, Bergeron A, Clement L, Lacroix C, Herbrecht R, Legrand F, Mohty M, Michallet M, Cordonnier C, Malak S, Guyotat D, Couderc LJ, Socié G, Milpied N, Lortholary O, Ribaud P.

Clin Microbiol Infect. 2012 Oct;18(10):E396-400. doi: 10.1111/j.1469-0691.2012.03908.x. Epub 2012 Jun 4.

Supplemental Content

Loading ...
Support Center